NCT05857917

Brief Summary

This clinical trial aims to investigate the effect of VR application on reducing preoperative anxiety and the intraoperative and postoperative pain of patients who undergo peritoneal dialysis catheter insertion. The main questions it aims to answer are: 1) Whether preoperative VR application can reduce preoperative anxiety in patients undergoing peritoneal dialysis catheter insertion; 2) Whether intraoperative VR application can reduce intraoperative and postoperative pain in patients undergoing peritoneal dialysis catheter insertion; 3) Whether VR application can improve patients satisfaction of the operation. Participants will be randomly assigned to the VR group and control group, and participants in the VR group will be introduced to VR use and watch a VR video about the operating room environment 1 day before the surgery. During the procedure, participants in the VR group will watch a soothing video through the VR device. In contrast, participants in the control group will receive the usual preoperative and surgical procedures. Preoperative anxiety, intraoperative and postoperative pain, and patient satisfaction will be compared between the two arms.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 17, 2023

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

April 19, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

May 15, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2023

Completed
Last Updated

May 15, 2023

Status Verified

May 1, 2023

Enrollment Period

7 months

First QC Date

April 19, 2023

Last Update Submit

May 4, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Procedure-related pain

    Measured by Visual Analogue Scale (VAS) pain measurement scale divided from 0 to 10 where 0 is no pain and 10 worst pain that can be imagined.

    recorded within 30 minutes after surgery

  • Anxiety assessment 30 minutes before surgery

    State-Trait Anxiety Scale (STAI) was applied in the preoperative period, and only the 20-item state scale construct was used.

    30 minutes before surgery

  • Patient satisfaction

    5-point Likert verbal rating scale: 5, extremely satisfied; 4, satisfied; 3, undecided; 2, dissatisfied; 1, extremely dissatisfied.

    within 30 minutes after surgery

Secondary Outcomes (6)

  • Postoperative analgesics usage

    after the operation until discharge from hospital

  • Distribution of systolic blood pressure of patients in the intraoperative period

    Baseline values are measured 30 minutes before the procedure, then the values at 5 minutes after the start of the procedure and every 15 minutes thereafter are recorded.

  • Distribution of diastolic blood pressure of patients in the intraoperative period

    Baseline values are measured 30 minutes before the procedure, then the values at 5 minutes after the start of the procedure and every 15 minutes thereafter are recorded.

  • Distribution of pulse rates of patients in the intraoperative period

    Baseline values are measured 30 minutes before the procedure, then the values at 5 minutes after the start of the procedure and every 15 minutes thereafter are recorded.

  • Distribution of respiratory rates of patients in the intraoperative period

    Baseline values are measured 30 minutes before the procedure, then the values at 5 minutes after the start of the procedure and every 15 minutes thereafter are recorded.

  • +1 more secondary outcomes

Other Outcomes (2)

  • VR Questionnaire

    within 30 minutes after surgery

  • Catheter insertion related complications

    through study completion, an average of 10 days

Study Arms (2)

VR group

EXPERIMENTAL

Participants randomized into this group will be introduced to VR use and watch a VR video that introduces the operating room environment 1 day before surgery and play a soothing video through VR during the surgery.

Device: Virtual Reality

Standard care group

NO INTERVENTION

The participants randomized to this group will receive the usual standard preoperative and intraoperative management.

Interventions

Virtual reality in PD catheter insertion surgery in the pre- and intraoperative setting.

VR group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-65 years, male or female.
  • Patients receiving PD catheter insertion for the first time.
  • Signed informed consent form.

You may not qualify if:

  • Hearing and vision impairments, or affective disorder.
  • Communication is not possible due to impaired cognitive ability.
  • History of epilepsy or seizure.
  • History of long-term use of pain medication (opioids).
  • History of severe cardiac failure (NYHA IV), acute myocardial infarction, or severe acute infection in recent three months.
  • Patients who refuse to use VR.
  • Other conditions deemed unsuitable by physicians.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First affiliated hospital of Sun Yat-sen University

Guangzhou, Guangdong, 510080, China

RECRUITING

Central Study Contacts

Wei Chen, M.D., Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 19, 2023

First Posted

May 15, 2023

Study Start

April 17, 2023

Primary Completion

October 30, 2023

Study Completion

October 30, 2023

Last Updated

May 15, 2023

Record last verified: 2023-05

Locations